Vertraagde tijd
Bombay S.E.
10:08:37 27-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.510
INR
|
-0,78%
|
|
+2,72%
|
+19,87%
|
Fiscaal tijdperk: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
1.148.922
|
845.286
|
1.434.322
|
2.194.737
|
2.358.729
|
3.649.748
|
-
|
-
|
Bedrijfswaarde
1 |
1.131.107
|
797.926
|
1.363.238
|
2.077.371
|
2.269.278
|
3.725.634
|
3.504.359
|
3.428.231
|
K/w-verhouding
|
43,1
x
|
22,5
x
|
49,4
x
|
67,3
x
|
27,8
x
|
40,6
x
|
33,2
x
|
28,6
x
|
Dividendrendement
|
0,57%
|
0,28%
|
1,25%
|
1,09%
|
1,17%
|
0,83%
|
0,93%
|
1,03%
|
Marktkapitalisatie/omzet
|
3,95
x
|
2,57
x
|
4,28
x
|
5,68
x
|
5,37
x
|
8,02
x
|
6,87
x
|
6,19
x
|
Bedrijfswaarde/omzet
|
3,89
x
|
2,43
x
|
4,07
x
|
5,37
x
|
5,17
x
|
7,68
x
|
6,59
x
|
5,81
x
|
Bedrijfswaarde/EBITDA
|
17,9
x
|
11,4
x
|
16,1
x
|
20
x
|
19,5
x
|
29,7
x
|
24,6
x
|
20,7
x
|
Bedrijfswaarde/FCF
|
-111
x
|
15,9
x
|
27,3
x
|
27,7
x
|
79
x
|
37,5
x
|
39,5
x
|
30,4
x
|
FCF Yield
|
-0,9%
|
6,28%
|
3,67%
|
3,61%
|
1,27%
|
2,67%
|
2,53%
|
3,29%
|
Price to Book
|
2,77
x
|
1,87
x
|
3,09
x
|
4,57
x
|
4,21
x
|
6,11
x
|
5,08
x
|
4,48
x
|
Aantal aandelen (in duizenden)
|
2.399.335
|
2.399.335
|
2.399.335
|
2.399.276
|
2.399.276
|
2.399.335
|
-
|
-
|
Referentieprijs
2 |
478,8
|
352,3
|
597,8
|
914,8
|
983,1
|
1.521
|
1.521
|
1.521
|
Datum van publicatie
|
28-05-19
|
27-05-20
|
27-05-21
|
30-05-22
|
26-05-23
|
22-05-24
|
-
|
-
|
Fiscaal tijdperk: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
290.659
|
328.375
|
334.981
|
386.545
|
438.857
|
484.968
|
531.557
|
589.734
|
EBITDA
1 |
63.076
|
69.898
|
84.914
|
103.977
|
116.468
|
125.288
|
142.729
|
165.218
|
Bedrijfsresultaat (EBIT)
1 |
45.543
|
49.370
|
64.114
|
82.540
|
91.174
|
99.722
|
118.091
|
138.551
|
Operationele Marge
|
15,67%
|
15,03%
|
19,14%
|
21,35%
|
20,78%
|
20,56%
|
22,22%
|
23,49%
|
Resultaat voor belastingen (EBT)
1 |
38.102
|
50.096
|
27.994
|
44.813
|
94.084
|
110.879
|
128.454
|
151.026
|
Nettowinst (verlies)
1 |
26.654
|
37.649
|
29.038
|
32.727
|
84.736
|
95.764
|
109.968
|
128.005
|
Nettomarge
|
9,17%
|
11,47%
|
8,67%
|
8,47%
|
19,31%
|
19,75%
|
20,69%
|
21,71%
|
WPA
2 |
11,11
|
15,69
|
12,10
|
13,60
|
35,30
|
39,90
|
45,78
|
53,27
|
Free Cash Flow
1 |
-10.164
|
50.128
|
50.002
|
74.895
|
28.738
|
99.332
|
88.792
|
112.871
|
FCF-marge
|
-3,5%
|
15,27%
|
14,93%
|
19,38%
|
6,55%
|
20,48%
|
16,7%
|
19,14%
|
Kasstroomconversie (ebitda)
|
-
|
71,72%
|
58,89%
|
72,03%
|
24,67%
|
79,28%
|
62,21%
|
68,32%
|
Kasstroomconversie (nettowinst)
|
-
|
133,14%
|
172,2%
|
228,85%
|
33,91%
|
103,73%
|
80,74%
|
88,18%
|
Dividend per aandeel
2 |
2,750
|
1,000
|
7,500
|
10,00
|
11,50
|
13,50
|
14,09
|
15,60
|
Datum van publicatie
|
28-05-19
|
27-05-20
|
27-05-21
|
30-05-22
|
26-05-23
|
22-05-24
|
-
|
-
|
Fiscaal tijdperk: Maart |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
88.368
|
85.230
|
97.187
|
96.259
|
98.631
|
94.468
|
107.618
|
109.523
|
112.410
|
109.307
|
119.408
|
120.786
|
122.741
|
121.964
|
128.967
|
EBITDA
1 |
24.061
|
20.484
|
28.211
|
26.299
|
26.063
|
23.404
|
28.844
|
29.566
|
30.037
|
28.021
|
33.318
|
32.390
|
33.096
|
31.857
|
33.436
|
Bedrijfsresultaat (EBIT)
1 |
18.742
|
14.950
|
23.179
|
20.996
|
20.526
|
17.839
|
22.964
|
23.466
|
23.438
|
21.306
|
26.804
|
23.673
|
27.405
|
24.698
|
26.622
|
Operationele Marge
|
21,21%
|
17,54%
|
23,85%
|
21,81%
|
20,81%
|
18,88%
|
21,34%
|
21,43%
|
20,85%
|
19,49%
|
22,45%
|
19,6%
|
22,33%
|
20,25%
|
20,64%
|
Resultaat voor belastingen (EBT)
1 |
21.630
|
9.030
|
18.042
|
22.865
|
24.662
|
-20.756
|
22.848
|
24.124
|
24.715
|
22.397
|
24.811
|
26.568
|
27.807
|
28.313
|
29.647
|
Nettowinst (verlies)
1 |
18.525
|
8.942
|
14.442
|
20.470
|
20.588
|
-22.772
|
20.609
|
22.622
|
21.660
|
19.845
|
20.225
|
23.123
|
24.062
|
23.668
|
22.718
|
Nettomarge
|
20,96%
|
10,49%
|
14,86%
|
21,27%
|
20,87%
|
-24,11%
|
19,15%
|
20,66%
|
19,27%
|
18,16%
|
16,94%
|
19,14%
|
19,6%
|
19,41%
|
17,62%
|
WPA
2 |
7,720
|
3,700
|
6,000
|
-
|
8,600
|
-9,500
|
8,600
|
9,400
|
9,000
|
8,300
|
8,400
|
8,650
|
9,793
|
9,800
|
9,500
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29-01-21
|
27-05-21
|
30-07-21
|
02-11-21
|
31-01-22
|
30-05-22
|
29-07-22
|
01-11-22
|
31-01-23
|
26-05-23
|
03-08-23
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
17.814
|
47.360
|
71.085
|
117.366
|
89.450
|
162.609
|
145.389
|
221.517
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-10.164
|
50.128
|
50.002
|
74.895
|
28.738
|
99.332
|
88.792
|
112.871
|
ROE (netto-inkomsten/eigen vermogen)
|
9,25%
|
8,69%
|
6,33%
|
16,6%
|
16,6%
|
16%
|
15,9%
|
16,5%
|
ROA (netto-inkomsten/totale activa)
|
5,71%
|
5,66%
|
4,27%
|
11,4%
|
11,5%
|
11,5%
|
11,6%
|
11,9%
|
Totale activa
1 |
466.880
|
664.736
|
679.574
|
286.936
|
739.147
|
831.283
|
947.284
|
1.071.213
|
Nettoactief per aandeel
2 |
173,0
|
189,0
|
194,0
|
200,0
|
233,0
|
265,0
|
299,0
|
339,0
|
Cashflow per aandeel
2 |
9,150
|
27,30
|
25,70
|
37,30
|
20,70
|
50,60
|
43,20
|
52,00
|
Capex
1 |
32.128
|
15.420
|
11.701
|
14.950
|
20.856
|
22.018
|
20.265
|
19.933
|
Capex/omzet
|
11,05%
|
4,7%
|
3,49%
|
3,87%
|
4,75%
|
4,54%
|
3,81%
|
3,38%
|
Datum van publicatie
|
28-05-19
|
27-05-20
|
27-05-21
|
30-05-22
|
26-05-23
|
22-05-24
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
1.521
INR Gemiddelde koersdoel
1.620
INR Spread / Gemiddelde doel +6,52% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +26,21% | 22,79 mld. | | +20,25% | 15,45 mld. | | +17,83% | 14,29 mld. | | +53,18% | 12,83 mld. | | -0,05% | 6,79 mld. | | -11,88% | 6,52 mld. | | +12,62% | 5,59 mld. | | -8,87% | 5,73 mld. | | +9,77% | 4,73 mld. |
Generieke geneesmiddelen
|